Growth Metrics

Bioregenx (BRGX) Cash from Investing Activities (2023 - 2025)

Bioregenx has reported Cash from Investing Activities over the past 3 years, most recently at -$3057.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 215.27% year-over-year to -$3057.0; the TTM value through Dec 2025 reached -$59057.0, up 68.58%, while the annual FY2025 figure was -$59057.0, 68.58% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$3057.0 at Bioregenx, up from -$6000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $2652.0 in Q4 2024 and troughed at -$199363.0 in Q4 2023.
  • A 3-year average of -$74394.2 and a median of -$28000.0 in 2025 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 101.33% in 2024 and later tumbled 215.27% in 2025.
  • Year by year, Cash from Investing Activities stood at -$199363.0 in 2023, then skyrocketed by 101.33% to $2652.0 in 2024, then tumbled by 215.27% to -$3057.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for BRGX at -$3057.0 in Q4 2025, -$6000.0 in Q3 2025, and -$50000.0 in Q2 2025.